In order to perform multi-scale characterisation and explore the heterogeneity of HRD, we present a mutational signature-based classifier of HRD for exome-sequenced breast cancers which we then apply to develop a transcriptional signature of HRD and BRCA1/2 deficiency. Here, BRCA1 is linked to breast carcinoma.